WASHINGTON (AP) - Eli Lilly & Co. has halted a pediatric study of its sepsis treatment Xigris, saying the drug was showing no benefit for children with the severe bloodstream infection and there was a sign of a possible serious side effect....More
Friday, April 29, 2005
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment